• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A potential preventive effect of fecal microbiota transplantation and 5-aminolevulinic acid against anti-cancer drug-induced damage to intestinal mucosa

Research Project

Project/Area Number 16K08921
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Applied pharmacology
Research InstitutionKawasaki Medical School

Principal Investigator

Takaoka Munenori  川崎医科大学, 医学部, 講師 (50548568)

Co-Investigator(Kenkyū-buntansha) 猶本 良夫  川崎医科大学, 医学部, 教授 (00237190)
Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2018: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2017: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2016: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Keywords薬剤性消化管粘膜障害 / 5-アミノレブリン酸 / オルガノイド / heme oxygenase-1 / 5‐アミノレブリン酸 / プロバイオティクス / 薬剤性消化管障害 / 医薬品副作用・薬物相互作用
Outline of Final Research Achievements

We utilized organoid culture established from mouse intestinal epithelium, and focused on the study of 5-aminolevulinic acid (5-ALA)-mediated protective effect on a damage to the intestinal mucosa by anticancer drugs.
In two-dimensional culture with commercially available rat intestinal epithelial cells, 5-ALA treatment could induce heme oxygenase-1 (HO-1), a major survival signal molecule that responds to oxidative stress. Under the treatment with SN-38, an active metabolite of a popular anticancer drug CPT-11 (Irinotecan), which is known to injure intestinal mucosa, the addition of 5-ALA could maintain the expression of HO-1 in rat intestinal epithelial cells but not without 5-ALA. We also observed the similar phenomenon in mouse intestinal organoid. Furthermore, 5-ALA treatment could reduce a chance of cell death by SN-38 treatment in this culture setting, suggesting that 5-ALA can be a potential supportive reagent against anticancer drug-induced damage to intestinal mucosa.

Academic Significance and Societal Importance of the Research Achievements

化学療法における5-ALAの腸管粘膜保護効果については理論的に妥当であるものの未だ報告がなかったため、本研究における5-ALAの消化管粘膜保護作用の研究成果には新規性を有する。故に、近い将来に化学療法に対する新規支持療法として臨床応用が期待される。
さらに、5-ALA合成能を高めたプロバイオティクス製剤創出に向けての新たな研究・開発へのステップを踏み出すことが可能となれば、実臨床の観点からも画期的である。5-ALAと既存のプロバイオティクス製剤との併用療法、すなわちシンバイオティクスを考案することができれば、社会的意義へつながるものと期待される。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (1 results)

All 2019

All Presentation (1 results)

  • [Presentation] 抗がん化学療法での消化管粘膜障害に対するアミノレブリン酸による保護効果の可能性2019

    • Author(s)
      高岡宗徳
    • Organizer
      川崎医科大学学術集会
    • Related Report
      2018 Annual Research Report

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi